telmisartan has been researched along with Brain Hemorrhage, Cerebral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bressolle, C; Fichet, J | 1 |
| Chu, K; Jung, KH; Kim, EH; Kim, JM; Kim, M; Kim, SJ; Lee, ST; Park, DK; Roh, JK; Sinn, DI; Song, EC | 1 |
2 other study(ies) available for telmisartan and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Telmisartan for prevention of cardiovascular events.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cerebral Hemorrhage; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan | 2009 |
Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Cerebral Hemorrhage; Inflammation; Neuroprotective Agents; Nitric Oxide Synthase Type III; Oxidative Stress; PPAR gamma; Rats; Telmisartan; Up-Regulation | 2007 |